Based on these results, HDAC7 is involved in WNT5A-mediated ESCC progression, and approaches targeting WNT5A and HDAC7 might be potential therapeutic strategies for ESCC. The gene discussed is WNT5A; the disease is esophageal squamous cell carcinoma.